Skip to main content
. 2019 Apr;207:80–89.e2. doi: 10.1016/j.jpeds.2018.11.022

Figure 1.

Figure 1

Consort diagram of study participant progression through the growth and biochemical assessments in the Lao Zinc Study. The micronutrient powder group received 1 micronutrient powder sachet daily (vitamin A [400 µg of retinol equivalents], thiamin [0.5 mg], riboflavin [0.5 mg], niacin [6 mg], vitamin B6 [0.5 mg], folic acid [150 µg of dietary folate equivalents], cyanocobalamin [0.9 µg], ascorbic acid [30 mg], cholecalciferol [5 mg], dl-α-tocopheryl acetate [5 mg of tocopherol equivalents], copper sulfate anhydrous [to provide 0.56 mg copper], potassium iodate [to provide 90 µg iodine], ferrous fumarate [to provide 6 mg of iron], selenium selenite [to provide 17 µg of selenium], zinc gluconate [to provide 10 mg of zinc]) and placebo tablet (1 per day for 10 days) during diarrhea episodes. The preventive zinc group (preventive zinc supplements) received 1 zinc tablet (7 mg/d) daily and placebo tablet (1 per day for 10 days) during diarrhea episodes. The therapeutic zinc group (therapeutic zinc supplements) received 1 placebo tablet daily and a 20-mg zinc tablet (1 per day for 10 days) during diarrhea episodes. Controls received 1 placebo powder sachet daily and placebo tablet (1 per day for 10 days) during diarrhea episodes. All children received ORS during diarrhea episodes, regardless of group allocation.